Gri Bio, INC. (GRI) — S-1/A Filings

All S-1/A filings from Gri Bio, INC.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (4)

GRI Bio Amends S-1, Updates Warrants and Engagement Letter — Dec 10, 2025 Risk: high
GRI Bio, Inc. filed an S-1/A on December 9, 2025, primarily as an exhibits-only amendment to its Registration Statement (File No. 333-291999). This filing did n
GRI Bio, Inc. Files S-1/A for Securities Registration — Mar 26, 2025 Risk: medium
GRI Bio, Inc. filed an S-1/A on March 26, 2025, to register securities. The company, formerly known as Vallon Pharmaceuticals, Inc. and GRI BIO, Inc., is incorp
GRI BIO, Inc. Amends S-1 Filing — Jun 26, 2024 Risk: medium
GRI BIO, Inc. filed an S-1/A on June 26, 2024, to amend its registration statement. The company, formerly Vallon Pharmaceuticals, Inc., is based in La Jolla, CA
GRI BIO, Inc. Files Amendment No. 1 to S-1 Registration Statement — Jan 31, 2024 Risk: medium
GRI BIO, Inc. (GRI) filed a Amended IPO Registration (S-1/A) with the SEC on January 31, 2024. GRI BIO, Inc. (formerly Vallon Pharmaceuticals, Inc.) filed an S-

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX